Food and Drug Administration
December 15, 2005
Briefing Information
ZOSTAVAX™ - Varicella Virus Vaccine Live (Oka/Merck)
FDA Clinical Briefing Document, Patricia Rohan, MD (HTM) (PDF)
FDA Statistical Review and Evaluation, Sang Ahnn, PhD (HTM) (PDF)
Disclaimer
The statements contained in this document(s) are those of the product's sponsor, not FDA, and FDA does not necessarily agree with the sponsor's statements. FDA has not made a final determination about the safety or effectiveness of the product described in this document.
ZOSTAVAX™ - Varicella Virus Vaccine Live (Oka/Merck), Merck Research Laboratories (PDF)